Experiences with
Coronavirus infection10,576 public posts
New Greek consensus statement for the treatment of chronic lymphocytic leukemia
experienced more frequently grade ≥3 adverse events, such as neutropenia and thrombocytopenia.¹⁸ Another important issue concerning the addition of Obinutuzumab to Acalabrutinib concerns the increased vulnerability of patients with CLL receiving anti-CD20 antibodies to severe coronavirus
Want to take advantage of all our features? Just log in!
or
New nasal COVID-19 vaccine developed by TAU
“When the COVID-19 pandemic began, we set a new goal: training our cancer platform to identify and target the coronavirus. Unlike Moderna and Pfizer, we did not rely on full protein expression via mRNA.
A+LUK Long Covid Webinar - latest research into Post Covid syndrome and treatment
There are many people in our community who are still struggling with a range of symptoms including breathlessness, since having Covid.
On 12th March at 6.30pm, we will be hosting a free online webinar-
Latest research into Post Covid Syndrome and treatment
We will be joined by Professor Rachael
A+LUK Long Covid Webinar - latest research into Post Covid syndrome and treatment
There are many people in our community who are still struggling with a range of symptoms including breathlessness, since having Covid.
On 12th March at 6.30pm, we will be hosting a free online webinar-
Latest research into Post Covid Syndrome and treatment
We will be joined by Professor Rachael Evans
2025 Spring -Information only - NHS England notification of contingent liability - COVID-19 spring 2025 vaccination programme
Please note this covers NHS England - and is information only at this time -
https://www.gov.uk/government/publications/departmental-minute-on-the-covid-19-spring-2025-vaccination-programme/departmental-minute-from-the-department-of-health-and-social-care-notification-of-contingent-liability-covid-